PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20455087-3 2010 Both retinoic acid (RA) and arsenic trioxide directly target PML/RARA-mediated transcriptional repression and protein stability, inducing rapid differentiation of the promyelocytes and clinical remission in most APL patients. Tretinoin 5-18 PML nuclear body scaffold Homo sapiens 61-64 20455087-3 2010 Both retinoic acid (RA) and arsenic trioxide directly target PML/RARA-mediated transcriptional repression and protein stability, inducing rapid differentiation of the promyelocytes and clinical remission in most APL patients. Tretinoin 20-22 PML nuclear body scaffold Homo sapiens 61-64